In March 2025, the company declared new options for any immediate-to-client presenting of its Wegovy weight loss drug. The company established a new pharmacy, called NovoCare, which might charge prospects $499 per 30 days for use of the drug, under fifty percent the cost of the drug by other pharmaceutical distribution networks.[53]Wegovy® include